These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24386193)

  • 1. Determination of HER2 amplification status on tumour DNA by digital PCR.
    Garcia-Murillas I; Lambros M; Turner NC
    PLoS One; 2013; 8(12):e83409. PubMed ID: 24386193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive detection of HER2 amplification with plasma DNA digital PCR.
    Gevensleben H; Garcia-Murillas I; Graeser MK; Schiavon G; Osin P; Parton M; Smith IE; Ashworth A; Turner NC
    Clin Cancer Res; 2013 Jun; 19(12):3276-84. PubMed ID: 23637122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues.
    Tantiwetrueangdet A; Panvichian R; Wongwaisayawan S; Sueangoen N; Lertsithichai P
    Med Oncol; 2018 Oct; 35(12):149. PubMed ID: 30284063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
    Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
    Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing HER2 Amplification in Plasma cfDNA.
    Garcia-Murillas I; Turner NC
    Methods Mol Biol; 2018; 1768():161-172. PubMed ID: 29717443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HER2 amplification in formalin-fixed paraffin-embedded breast carcinoma tissue with digital PCR using two TFF3 sequences as internal reference.
    Yu R; Xuan W; Zhou L; Luo Y; Liu X; Xiong P; Ren X
    Exp Mol Pathol; 2018 Jun; 104(3):235-238. PubMed ID: 29715436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.
    Lamy PJ; Fina F; Bascoul-Mollevi C; Laberenne AC; Martin PM; Ouafik L; Jacot W
    Breast Cancer Res; 2011 Feb; 13(1):R15. PubMed ID: 21288332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis.
    Wang Y; Tsang JYS; Cui Y; Cui J; Lin Y; Zhao S; Law PTW; Cheung SY; Ng EKO; Tse GMK; Ke Z
    Sci Rep; 2017 Jul; 7(1):6752. PubMed ID: 28754904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of Chromosome 17 Centromere (CEP17) in Breast Cancer Patients with a Result of HER2 2± by Immunohistochemistry.
    Davies V; Voutsadakis IA
    Cancer Invest; 2020 Feb; 38(2):94-101. PubMed ID: 31977265
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification.
    Ercolani C; Marchiò C; Di Benedetto A; Fabi A; Perracchio L; Vici P; Sperati F; Buglioni S; Arena V; Pescarmona E; Sapino A; Terrenato I; Mottolese M
    J Exp Clin Cancer Res; 2017 Oct; 36(1):143. PubMed ID: 29029640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients.
    Otsuji K; Sasaki T; Tanaka A; Kunita A; Ikemura M; Matsusaka K; Tada K; Fukayama M; Seto Y
    Breast Cancer Res Treat; 2017 Feb; 162(1):11-18. PubMed ID: 28039535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits.
    Pekar G; Kasselaki I; Pekar-Lukacs A; Dekany C; Hellberg D; Tot T
    Histopathology; 2019 Jan; 74(2):300-310. PubMed ID: 30113715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens.
    Matsusaka K; Ishikawa S; Nakayama A; Ushiku T; Nishimoto A; Urabe M; Kaneko N; Kunita A; Kaneda A; Aburatani H; Fujishiro M; Seto Y; Fukayama M
    PLoS One; 2016; 11(4):e0154430. PubMed ID: 27119558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number.
    Jang MH; Kim EJ; Kim HJ; Chung YR; Park SY
    Breast Cancer Res Treat; 2015 Aug; 153(1):67-77. PubMed ID: 26223814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
    Fountzilas G; Dafni U; Bobos M; Kotoula V; Batistatou A; Xanthakis I; Papadimitriou C; Kostopoulos I; Koletsa T; Tsolaki E; Televantou D; Timotheadou E; Koutras A; Klouvas G; Samantas E; Pisanidis N; Karanikiotis C; Sfakianaki I; Pavlidis N; Gogas H; Linardou H; Kalogeras KT; Pectasides D; Dimopoulos MA
    BMC Cancer; 2013 Mar; 13():163. PubMed ID: 23537287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression.
    Chen PC; Yu HJ; Chang YH; Pan CC
    J Clin Pathol; 2013 Feb; 66(2):113-9. PubMed ID: 23087329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
    Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
    Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and amplification of Topoisomerase-2α in type 1 and type 2 papillary renal cell carcinomas and its correlation with HER2/neu amplification.
    Duzcan F; Duzcan SE; Sen S; Yorukoglu K; Caner V; Sen Turk N; Cetin GO; Kelten C; Tuna B; Sarsik B; Tepeli E
    Pathol Oncol Res; 2011 Sep; 17(3):697-703. PubMed ID: 21461646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
    Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
    Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.